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1.2 Abstract  
  
Objective: Stroke is a devastating neurological condition affecting over 150,000 
people in the United Kingdom every year with an individual suffering a stroke 
approximately every three and a half minutes. The collateral circulation plays an 
important role in maintaining  blood flow to the tissue that is at risk of developing 
ischaemia. The aim of my study was to assess the role of collaterals in the 
development of ischaemic tissue and in clinical outcome.  
  
Methods: Data was derived from a large international study (The SOS Trial: A 
Study of Survival and Outcome after Stroke ClinicalTrials.gov Identifier: 
NCT01193569).  For all enrolled patients, functional outcome was defined by the 
modified Rankin Scale (mRS) determined at 90 days after the index event. 
Collaterals on CT-Angiography (CTA) were scored using the Tan score. This was 
correlated to development of ischaemic regions using the ASPECTS score as well as 
the clinical outcome score NIHSS.  
  
  
Results: My results show that an increasing TAN score appears to be associated with 
a lower mRS score (p=0.048; 95% CI). There was a positive correlation between 
ASPECTS score and Tan score (p=0.049). M2 and M4 regions were associated with 
an increase in NIHSS (p=  
0.027; 0.009); M2 and M5 regions were associated with an increase in mRS  
 (p= 0.019; 0.023). An increase in ASPECTS score (less damage) implied a reduction 
in the NIHSS and mRS score (better outcome).  
  
  
Conclusion: Our results have potentially a huge impact on patient selection, as they 
demonstrate that patients with good collaterals should be transferred for treatment to 
tertiary care centres for thrombectomy or patient selection according to the 
salvageability of specific functions. This will hopefully allow patients to have better 
outcomes after suffering a stroke  and reduce morbidity and disability in the long 
term. More work is required to elucidate further prognostic markers for collateral 
formation and outcome.   
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 2  Introduction  
  
Stroke is a devastating neurological condition affecting over 150,000 people in the 
United Kingdom every year with an individual suffering a stroke approximately 
every three and a half minutes (Stroke Association., 2016). The collateral circulation 
plays an important role in  maintaining blood flow (Bang et al., 2008) to the tissue 
that is at risk of developing ischaemia. The aim of my study was to measure 
collateral flow using CT-angiographic data and to see if collaterals can help identify 
areas of the brain that are at risk of infarction but may still be salvageable. My 
research thus focused on patients with known major vessel occlusion (MVO) from a 
large international study (The SOS Trial: A Study of Survival and Outcome after 
Stroke ClinicalTrials.gov Identifier: NCT01193569).  Patients included in the study 
presented with acute ischaemic stroke from large vessel thromboembolism in the 
brain.   
The target population was a stroke cohort with a known infarct volume who 
presented within 8 hours from symptom onset with a NIH stroke scale (NIHSS) 
score of ≥10. Functional  outcome as defined by the Modified Rankin Scale (mRS) 
was determined at 90 days after the index event for all enrolled patients. CTA 
imaging was correlated using the TAN score to elucidate collateral formation.   
  
To the best of my knowledge, my MD project is the first study to evaluate a cohort of 
patients with persistent MVO for their collateral status and its impact on outcome.   
  
There are two types of stroke, ischaemic and haemorrhagic. My thesis will focus on 
ischaemic stroke which makes up approximately nine out of ten stroke cases. 
Ischaemic stroke is the result of vessel occlusion from in situ thrombosis, embolism 
or haemodynamic failure. Embolism may be from artery to artery (30-40%) or from 
the heart such as an intramural thrombus or an irregular heart rhythm (30-40%) 
(Ntaios et al., 2017). In 25% of cases, disease of the tunic intima of small penetrating 
intracranial blood vessels is responsible for lacunar infarction (Howard., 2016).  
  
  
2.1 Management of acute stroke  
The first few hours after an ischaemic stroke are crucial and there are certain factors 
that need to be addressed to improve outcomes. Firstly, restoring blood flow by 
using thrombolysis to dissolve or break down an existing clot, thus reperfusing the 
area of the brain at risk. The most commonly used drug for thrombolytic therapy is 
tissue plasminogen activator (tPA). Another treatment of choice is endovascular 
mechanical thrombectomy which includes a wide range of endovascular tools 
approved for removing thrombi from the neurovasculature in acute ischaemic stroke 
patients. Evidence suggests that mechanical thrombectomy is appropriate for patients 
with large proximal intracranial artery occlusions due to emboli of cardiac or arterial 
origin.   
Recent studies confirmed that mechanical thrombectomy in combination with 
intravenous thrombolysis is an effective treatment for eligible patients (Mistry et al., 
2017).  
  
 Secondly, looking at collateral vessels and how they have an effect on preserving 
the ischaemic penumbra (the area surrounding the infarcted area) and the concept of 
neuroprotection (Newhaus et al., 2017). Thirdly, preventing recurrence with anti-
platelet therapy after the event. A haemorrhagic stroke will usually require surgery 
depending on the co-morbidities and the functional status of the patient.  
  
The initial management of acute stroke focuses on gaining a secure airway, assessing 
breathing and circulation, followed by an evaluation of the neurological deficits and 
comorbidities to identify patients who may be eligible for thrombolysis. It also 
involves identifying those at particular risk for complications of acute stroke. Ideally, 
patients should have imaging of their brain performed as soon as possible as well as 
thorough examination by the on-call stroke physicians.  
  
2.2 Imaging in Stroke  
Stroke is a major cause of mortality and long-term disability. More than 80% of 
strokes are from ischaemic damage to the brain due to acute reduction of blood 
supply. It was calculated that 1.8 million neurons are lost every minute that 
appropriate treatment is not given (‘time is brain’) (Saver., 2006). It is for this very 
reason that imaging in stroke is so vitally important and efficient.  
  
Approximately 25–35% of stroke patients present with large vessel occlusion 
(Malhotra et al., 2017). These patients often present with severe neurological deficits 
and prognosis is often poor if early treatment is not possible. This group of patients 
is the target for any endovascular intervention, thus appropriate patient selection 
based on clinical findings and neuroimaging are of utmost significance.  
  
Alongside bedside investigations (including an electrocardiogram to check for an 
irregular heart rhythm), observations and routine blood tests, it is crucial to perform 
a computed tomography (CT) or magnetic resonance imaging (MRI) scan, 
depending on what is available in hospitals, as soon as possible. Early CT scan 
changes are seen within 6 hours of stroke onset (Von Kummer et al., 1996); they 
include: cortical sulcal effacement, loss of the insular ribbon, blurring of the grey-
white interface, obscuration of lentiform nucleus and the hyperdense artery sign 
(intravascular thrombus) as demonstrated in (Fig.1) below. This will also suggest 
what type of intervention (thrombolysis vs thrombectomy) would be most beneficial.  
  
A cerebral and/or neck CT angiogram/magnetic resonance (MR) angiogram should 
be performed to exclude arterial dissection and carotid or vertebral occlusive disease. 
Brain haemodynamic measurements with CT or MRI perfusion allow the 
identification of viable tissue at risk of infarction (penumbra). Diffusion-weighted 
imaging (DWI) is the most reliable technique for detecting acute ischaemic stroke as 





Fig.1 Early changes in an acute stroke demonstrated by hyperdense left MCA sign (yellow arrow) in 
the left image, hypoattenuated left basal ganglia (red arrow) and cortical swelling (blue arrows) in the 
centre image.  
The right image shows a dot sign in the left sylvian fissure. (Figure adapted from Mankungiya, 2017).  
  
CT is the mainstay of imaging available in most hospitals on a round-the-clock basis. 
Use of CT imaging can readily exclude the presence of an acute cerebral 
haemorrhage, thus making a significant change in treatment management if required. 
Prior to performing a scan, the radiologist needs to collect certain clinical data, 
including the time of symptom onset, clinical findings including results of the 
National Institutes of Health Stroke Scale (NIHSS) and relevant patient history. The 
main goals of imaging are firstly to rule out intracranial haemorrhage (as this will 
determine treatment management), secondly to define the extent of ischaemic 
damage, to differentiate between the infarct core and the salvageable ischaemic 
penumbra (Gonzalez, 2012) and to visualise large blood vessel significance.  
  
In computed tomography angiography (CTA), iodinated contrast medium is 
administered intravenously. The scanning usually starts from the aortic arch up to a 
level above the circle of Willis when the contrast medium is in the arterial phase. 
Stenoses and occlusions can be detected with high diagnostic precision in both pre-
cranial and intracranial arteries thus revealing the origin of the acute ischaemic 
stroke. There is, however, a risk of an allergic reaction to the contrast medium and 
contraindications for patients with impaired renal function.  
  
Quantifying existing irreversible stroke damage and tissue at risk are crucial to identify 
patients who can benefit from endovascular treatment, especially as there is now level 
1A evidence for mechanical clot removal with improved patient outcome in large 
vessel occlusion (Powers et al., 2015). However, prediction of outcome is difficult, 




3  Aim   
  
The aim of this study was to evaluate the impact of collaterals on outcome in patients 
presenting with symptoms of acute ischaemic stroke within 8 hours from symptom 
onset with an imagingdefined large cerebral vessel occlusion and a known infarct 
volume. We postulate that collaterals, as seen on CT-Angiography in combination 
with eloquent areas are predictors of outcome after acute ischaemic stroke due to large 
vessel occlusion.  
  
3.1 Hypothesis  
  
We hypothesise that:  
1. There is a correlation between the collaterals (TAN score) and functional 
outcome (mRS; NIHSS)  
2. There is a correlation between the TAN score and the ASPECTS score  
3. Certain ASPECTS areas are correlated to functional outcome (mRS; NIHSS) 
4.  A higher ASPECTS score correlates to a lower NIHSS and mRS score  
 
  
4  Background 
 
4.1 Definition of Stroke   
  
The traditional definition of stroke is clinical and based upon the sudden onset of loss 
of neurological function due to infarction caused by ischaemia or haemorrhage (the 
two types of stroke) in an area of the brain, spinal cord or retina (Sacco et al., 2013). 
Stroke has the same origin as transient ischaemic attack (TIA) and the same symptoms; 
however, stroke symptoms  persist for more than 24 hours or may lead to an early 
death whereas blockage due to TIA will only last for a short time. As the definition is 
constantly being updated an addition to the above is adding in a requisite about 
imaging (computed tomography (CT) or magnetic resonance imaging (MRI)) and 
autopsy revealing ischaemia or haemorrhage causing stroke-like symptoms (Sacco et 
al., 2013).  
  
More than 80% of strokes stem from ischaemic damage to the brain due to the acute 
reduction of the blood supply (El-Koussy et al., 2014). It was calculated that 1.8 
million neurons are lost every minute that appropriate treatment is not given (Saver 
et al., 2006), hence the importance of the phrase ‘time is brain’.  
  
Stroke is subdivided according to the so-called TOAST criteria (Trial of Org 10172 in 
Acute Stroke Treatment) (Adams, 1993): the division is into cardio-embolic ischaemic 
infarcts, macroangiopathic arterio-arterial ischaemic infarcts, microangiopathic-
ischaemic brain infarcts, infarcts with other specific causes, e.g. haematological 
diseases, vasculopathies and undetermined causes.  
  
4.2 Management of acute stroke  
  
The first few hours after an ischaemic stroke are crucial and there are certain factors 
that need to be addressed to improve outcomes.   
  
Firstly, restoring blood flow, either by using thrombolysis or thrombectomy to break 
down, or remove an existing clot thus reperfusing the area of the brain at risk.  
   
Secondly, looking at collateral vessels and how they have an effect on preserving the 
ischaemic penumbra (the area surrounding the ischaemic infarct) and the concept of 
neuroprotection.   
  
Thirdly, preventing recurrence with antiplatelet therapy after the event. A 
haemorrhagic stroke will usually require surgery depending on the co-morbidities and 
functional status of the patient.  
  
The initial management of acute stroke focuses on gaining a secure airway, assessing 
breathing and circulation, followed by an evaluation of the neurological deficits and 
co-morbidities to identify patients who may be eligible for thrombolysis or 
thrombectomy. Obtaining a history  of events, possibly from the patient or a relative, 
is crucial as it provides the clinician with a timeline. It also enables identifying those 
at particular risk for complications of acute stroke.    
  
4.3 Socio-economic importance  
  
Stroke is a disease of increasing socio-economic importance in aging societies. By 
2020, stroke and coronary heart disease are expected to be the leading causes of loss 
of a healthy life. (Feigin et al., 2003). Two thirds of all stroke survivors suffer from 
persistent disability. Among them, motor restriction is the most common (Feigin et al., 
2003).  
  
Depending on the location and size of the infarction, there will be typical neurological 
deficits and / or psychopathological symptoms. Thus, clinical neurological deficits 
after a cerebral infarction may include sensorimotor hemiparesis, disturbance of 
consciousness, aphasia or dysarthria. These may be transient as in transient ischaemic 
attack (TIA) with symptoms usually lasting less than 24 hours or persistent as a 
definitive ischaemic stroke. In the vast majority of cases, patients survive the acute 
stage but long-term recovery is varying strongly. Sudden hypoperfusion of the 
supratentorial brain causes a supply deficit with oxygen and glucose with often 
permanent damage (Rink et al., 2011).  
  
Two thirds of all patients who survive a stroke suffer from persistent disability. Among 
them, motor restriction is the most common form of disability. Despite intensive 
physiotherapeutic, occupational therapy and sports medicine rehabilitation efforts, 60-
70% of all stroke patients still suffer from limited motor hand function six months after 
a cerebrovascular stroke event (Feigin V et al., 2003). Especially long-standing strokes, 
showing persistent hand dysfunction, show little signs of recovery so far.   
  
4.4 Clinical Assessment  
  
Clinical assessment of strokes is dependent of stroke location in the brain, i.e. which 
vessel(s) are affected. The majority of strokes are supratentorial; as such the 
acronym FAST, for facial droop, arm drop, speech disturbance and time can be used 
for clinical assessment. The most important historical feature of stroke is the 
suddenness of its onset. Almost half of strokes affect the large vessel, the middle 
cerebral artery (Ng et al., 2007).  
  
An occlusion of the middle cerebral artery (MCA) leads to contralateral brachiofacial 
sensorimotor hemiparesis, often with central facial palsy. If the dominant hemisphere 
is affected, patients may show aphasia. In anterior cerebral artery occlusion (ACA), 
patients suffer from contralateral limb sensorimotor hemiparesis and sometimes 
bladder dysfunction, as the lower extremity is represented by the homunculus schema 
at the mantle edge of the motor cortex. In infarcts of the posterior cerebral artery supply 
area, contralateral hyperaesthesia and homonymous hemianopia are contralateral. 
Basilar artery occlusion leads to damage to the brainstem and involves a high 
morbidity and mortality rate of 80-90% without active intervention (Yeung et al., 
2014). The cerebrum and occipital lobe are affected, which can lead to hemianopia or 
blindness. Thus, all brain stem symptoms and also cerebellar symptoms can be present. 
The symptoms range from blurred vision, speech disorders, dysphagia, peripheral 
paralysis, centralised respiratory disorder to decreased consciousness and coma. The 
most severe form of brain stem injury, caused by extensive occlusion of the basilar 
artery, results in high tetraplegia if the patient survives (Pantke et al., 2014) which is 
where the so-called locked-in syndrome is derived from and in which no motor 
function except the eyelid motor can be exercised with fully preserved consciousness.  
  
  
4.5 Modified Rankin Scale    
  
  
The Modified Rankin Scale (mRS) is a clinician-reported measure of global 
disability.  It is widely applied for evaluating stroke patient outcomes (Rankin, 1957 
and Van Swieten, 1988) and used as an endpoint in randomised clinical trials.   
  
The scale runs from 0-6, ranging from perfect health without symptoms to death. This 
is illustrated in (Table 1) below;  
  
  
0    No symptoms.  
1    No significant disability. Able to carry 
out all usual activities, despite some 
symptoms.  
2    Slight disability. Able to look after own 
affairs without assistance, but unable to 
carry out all previous activities.  
3    Moderate disability. Requires some 
help, but able to walk unassisted.  
4    Moderately severe disability. Unable to 
attend to own bodily needs without 
assistance, and unable to walk 
unassisted.  
5    Severe disability. Requires constant 
nursing care and attention, bedridden, 
incontinent.  
6    Dead.  
  
Table 1: Modified Rankin Scale for measuring the degree of disability or dependence in the daily 
activities of people who experience a stroke.  
  
  
The mRS has been used often as an endpoint in randomised controlled trials of acute 
ischaemic stroke treatments based on its straightforward application, acceptable 
inter-rater reliability, and ability to discriminate levels of stroke disability (Weimar 
et al., 2002 and Kwon et al., 2004). Optimising mRS endpoints for acute stroke 
treatment RCTs involves definition and appropriate statistical analyses. When 
properly administered, the mRS exhibits a strong relationship with clinical 
measurements of stroke severity in addition to other disability and outcome 
endpoints. Construct validity of the mRS has been affirmed by multiple studies in 
which it has been consistently observed that the location, type and extent of stroke 
injury are closely related to short and longer-term disability (Banks et al., 2007). 
However, clinicians should be aware that the mRS grading may be affected by a 
variety of factors, including patient co-morbidities and socio-economic status. Use of 
the mRS in RCTs may benefit from a carefully defined endpoint as well as from a 
form of statistical analysis that is most likely to accurately reflect the effect of 
treatment.  
  
4.6 MRC Grading  
  
Muscle strength post-stroke is assessed according to the British Medical Research 
Council.   
  
(The MRC Muscle Scale is licensed under the Open Government License).  
  
The muscle scale grades muscle power on a scale of 0 to 5 in relation to the maximum 
expected for that muscle. This is outlined below.  
  
Grade 0: no muscle activity  
  
Grade I: visible or palpable muscle contraction without any movement effect  
  
Grade II: movement effect with elimination of gravity  
  
Grade III: movements against gravity possible  
  
Grade IV: movements against moderate resistance  
  




4.7 NIHSS  
  
  
The National Institutes of Health Stroke Scale (NIHSS) is a systematic assessment tool 
that provides a quantitative measure of stroke-related neurologic deficit. The NIHSS 
was originally designed as a research tool to measure baseline data on patients in acute 
stroke clinical trials. At present, the scale is also widely used as a clinical assessment 
tool to evaluate the acuity of stroke patients, determine appropriate treatment, and 
predict patient outcome.  
  
The NIHSS can be used as a clinical stroke assessment tool to evaluate and record the 
neurological status in acute stroke patients (NIHSS, 2017). The stroke scale is valid 
for predicting the lesion size and can serve as a measure of stroke severity. The NIHSS 
has been shown to be a predictor of both short and long-term outcome of stroke 
patients. Additionally, the stroke scale serves as a data collection tool for planning 
patient care and provides clarity and simplicity among healthcare staff.   
  
The NIHSS is a 15-item neurological examination stroke scale used to evaluate the 
effect of acute cerebral infarction on the levels of consciousness: language, neglect, 
visual-field loss, extraocular movement, motor strength, ataxia, dysarthria, and 
sensory loss. A trained observer rates the patient’s ability to answer questions and 
perform activities. Ratings for each item are scored with 3 to 5 grades with 0 as normal, 
and there is an allowance for untestable items. The assessment of a patient usually 
requires about 10 minutes to complete, dependent on user experience.  
The scale is designed to be a simple, effective, and reliable tool that can be 
administered at the bedside by physicians, nurses or therapists but the evaluation of 
stroke severity depends upon the ability of the observer to accurately and consistently 
assess the patient. This is why clinical acumen and knowledge is crucial in difficult 
and not so straightforward cases.  
  
  
4.8 Imaging in Stroke  
  
Stroke is a major cause of mortality and long-term disability. More than 80% of strokes 
are from ischaemic damage to the brain due to the acute reduction of blood supply 
(Stroke Association, 2016). It was calculated that 1.8 million neurons are lost every 
minute that appropriate treatment is not given (‘time is brain’) (Saver, 2006). It is for 
this very reason that imaging in stroke is so vitally important and efficient.  
  
Approximately 25–35% of strokes show large vessel occlusions and patients in this 
category often present with severe neurological deficits and prognosis is often poor if 
early treatment is not possible (Smith et al., 2009). It is this group of patients who is 
the target for any endovascular intervention, thus appropriate patient selection based 
on clinical findings and neuroimaging are of utmost significance.  
  
Alongside bedside investigations (including an electrocardiogram to check for an 
irregular heart rhythm), observations and routine blood tests, it is crucial to perform a 
computed tomography (CT) or magnetic resonance imaging (MRI) scan, depending 
on what is available in hospitals as soon as possible. Early CT scan changes are seen 
in 60% (Fig.2) within 6 hours of stroke onset and they include: cortical sulcal 
effacement, loss of the insular ribbon, blurring of the grey-white interface (red arrow), 
obscuration of lentiform nucleus and the hyperdense artery sign (intravascular 
thrombus). This will also allow an idea of what type of intervention (thrombolysis vs 





Fig.2 CT Head scan showing a right sided ischaemic stroke (red arrow).  
  
A cerebral and/or neck CT angiogram/magnetic resonance (MR) angiogram should be 
performed to exclude arterial dissection and carotid or vertebral occlusive disease. 
Brain haemodynamic measurements with CT or MRI perfusion allow the 
identification of viable tissue at risk of infarction (penumbra). Diffusion-weighted 
imaging (DWI) is the most reliable technique for detecting acute ischaemic stroke as 
early as 30 minutes from symptom onset (Ledezma et al., 2009).  
  
CT is the mainstay of imaging available in most hospitals on a round-the-clock basis. 
Use of CT imaging can readily exclude the presence of an acute cerebral haemorrhage, 
thus making a significant change in treatment management if needed. Prior to 
performing a scan, the radiologist needs to collect certain clinical data including the 
time of symptom onset, clinical findings including results of the National Institute of 
Health Stroke Scale (NIHSS) and relevant patient history. The main goals of imaging 
are firstly to rule out intracranial haemorrhage (as this will determine treatment 
management), secondly to define the extent of ischaemic damage, to differentiate 
between the infarct core and the salvageable ischaemic penumbra (Gonzalez., 2012) 
and to visualise large blood vessel significance.  
  
In computed tomography angiography (CTA), iodinated contrast medium is 
administered intravenously. The scanning usually starts from the aortic arch up to a 
level above the circle of Willis when the contrast medium is in the arterial phase. 
Stenoses and occlusions can be detected with high diagnostic precision in both pre-
cranial and intracranial arteries thus revealing the origin of the acute ischaemic 
stroke. There is, however, a risk of an allergic  reaction to the contrast medium and 
contraindications for patients with impaired renal function.  
  
4.9 ASPECTS  
  
The extent of ischaemic damage as detected on CT or MRI can be measured by 
visualising, semi-quantitatively with the Alberta stroke program early CT score 
(ASPECTS) (Pexman et al., 2001). ASPECTS is a 10-point quantitative topographic 
CT scan score used in patients with middle cerebral artery (MCA) stroke. Segmental 
assessment of the MCA vascular territory is performed and 1 point is deducted from 
the initial score of 10 for every region involved.  
  
ASPECTS is determined from evaluation of two standardised regions of the MCA 
territory: The basal ganglia level, where the thalamus, basal ganglia, and caudate are 
visible, and the supra-ganglionic level, which includes the corona radiata and centrum 
semi-ovale (see Fig.3 below).  
  
Fig. 3 C- Head of caudate nucleus, I- Insula, IC- Internal capsule, L- Lentiform nucleus, Cortical 
regions (M1M6). CT representation of ASPECTS regions and 10 MCA regions. Figure from 
https://radiopaedia.org/articles/albertastroke-program-early-ct-score-aspects-1  
  
All imaging cuts with basal ganglionic or supra-ganglionic structures visible are 
required to determine if an area is involved. The abnormality should be visible on at 
least two consecutive cuts to ensure that it is truly abnormal rather than a volume 
averaging effect. To compute the ASPECTS, 1 point is subtracted from 10 for any 
evidence of early ischaemic change for each of the defined regions. A normal CT scan 
receives an ASPECT score of 10 points. A score of 0 indicates diffuse involvement 
throughout the MCA territory.   
  
So how do we use ASPECTS in the clinical environment? Within the first three hours 
of an MCA stroke onset, baseline ASPECTS values correlate inversely with the 
severity of NIHSS and with functional outcome which is an important factor in 
prognosis (Pfaff et al., 2007).  
  
If the area of hypodense acute ischaemic change is larger than one-third of the MCA 
territory, reperfusion therapy is contraindicated. This is where ASPECTS can also be 
helpful in identifying patients not suitable for revascularisation (Jauch et al., 2013). 
Overall, patients with an ASPECTS below 7 are less likely to benefit from 
thrombolysis. ASPECTS is however limited by specifically only looking at the middle 
cerebral artery, so anterior and posterior cerebral artery strokes cannot be directly 
correlated.  
  
4.10 CT-Angiography  
  
In many UK centres, angiography is performed directly after a non-contrast CT scan 
is obtained. The role of a non-contrast CT scan is to reveal any contraindications to 
thrombolysis or thrombectomy. Digital subtraction angiography (DSA) is the gold 
standard for assessing collaterals but is not always available and computed 
angiography (CTA) is a non-invasive alternative. CTA obtains a snapshot of the 
cerebral vessels and provides an approximation of the maximal extent of collaterals. 
As recruitment of collaterals is dynamic, multiphasic CTA has been proposed to 
capture the temporal information. CTA source images can also capture the dynamic 
aspect of collateral circulation (Tong., 2015). Allergy to the contrast dye and renal 
impairment are the two most common reasons for contraindications to having a CTA.  
  
4.11 Collaterals  
  
In acute ischaemic stroke, collateral circulation plays an important role in maintaining 
blood flow to the tissue that is at risk of progressing into ischaemia. In acute ischaemic 
stroke, tissues that remain alive despite low cerebral blood flow but that are at risk for 
progressing into infarction are considered to be “ischaemic penumbra” (Paciaroni et 
al., 2009). Both intravenous thrombolysis and endovascular therapies can rescue 
penumbral tissue by recanalising occluded cerebral arteries. However, even after 
successful recanalisation, some patients show little neurologic improvement, possibly 
because the penumbral area had already progressed into the irreversibly damaged 
ischaemic core or because haemorrhagic transformation occurred after the 
recanalisation therapy. Collateral circulation has the potential to protect against these 
ischaemic injuries by maintaining cerebral blood flow, thus saving brain tissue.  
  
Since collateral status is being increasingly recognised as a promising biomarker for 
patient selection in stroke treatment, there are ongoing efforts to develop a 
standardised collateral grading system.   
  
The last decade has seen numerous advances in neuroimaging and acute ischaemic 
stroke therapy (Wintermark et al., 2008 & Kim et al., 2015), especially with the 
development of endovascular therapy as an approach to blood flow restoration. An 
essential part is finding the correct conditions for reperfusion that prevent any further 
damage to cells in the brain without the risk of haemorrhagic transformation. 
Measuring collateral flow using angiography can help identify areas of the brain that 
are at risk of infarction and haemorrhage. Collateral vessels can  sustain ischaemic 
regions in the brain when the primary source of arterial blood inflow is shut off. Both 
factors (site of ischaemia and reperfusion vessels) are important determinants of good 
outcomes for stroke patients.  
  
An example image is shown below (Fig.4)  
  
  
Fig.4 a. CTA performed showing image on left side, visible collaterals noted in M1, M2, M3 
regions. b. On right side showing occlusion of the left-MCA.  
 
In the subsequent digital subtraction angiography (DSA) image (see Fig.5 below), we 
can see  occlusion of the left MCA (white arrow) and good collateral supply (black 
arrows). One method of assessing collaterals is by using the TAN system (Tan et al., 
2007) and this image would represent a TAN score of 3. Further details will be 
discussed in section (4.13.3).  
  
a  b  
 
  
Fig.5 DSA image showing an occluded left MCA (white arrow) and good collateral supply (black 
arrows).  
  
MRI DWI image of the same patient below (Fig.6) shows a smaller infarct due to 




Fig.6 MRI DWI showing a small left sided infarct (white arrow).  
  
This shows the importance of collateral flow in saving brain tissue and overall in 
reducing infarct size.  
  
Cerebral collateral circulation provides subsidiary blood flow to oligaemic brain tissue 
when the primary feeding artery is severely stenosed or occluded. The artery anatomy 
of collateral circulation includes the Circle of Willis (CW), large-artery 
communications between the extracranial artery and intracranial artery and 
leptomeningeal anastomoses that links distal sections of major cerebral arteries. The 
former is considered as a primary collateral and the latter two as secondary collaterals 
(Shuaib et al., 2011). The effectiveness of primary collaterals mainly relies on the 
integrity of the CW. A complete CW, if exists, is usually robust enough to compensate 
the decreased blood flow caused by a chronic or even abrupt occlusion lying 
proximally to it. However, absence or hypoplasia of one or more segments of CW is 
not rare (Kluwer et al., 1998) which may impair its effectiveness of redistributing 
blood. Capacity of secondary collaterals such as leptomeningeal anastomoses is 
affected by much more factors than primary collaterals is. Great variation exists in 
secondary collateral status of healthy adults.  
  
4.12 Angiographic grading systems  
  
Arteriographic demonstration of flow restoration or revascularisation, has two 
components: recanalisation of the original or primary arterial occlusive lesion and 
reperfusion past the occlusion and into the distal arterial bed and terminal branches 
with tissue staining. Complete recanalisation of the primary occlusion may have 
variable distal patency and perfusion/reperfusion. Complete proximal recanalisation 
with limited distal perfusion may be associated with a greater central haemorrhage risk 
into areas supplied by injured penetrating arteries subjected to altered pulse pressures 
(Tomsick., 2007). With the increasing number of acute ischaemic stroke studies, 
standards for design and reporting were proposed in 2003 by Higashida et al., 
including recommendations of the Thrombolysis in Cerebral Infarction (TICI) scale. 
The TICI grading approach (see Table 2) uses contrast filling and clearance time to 
further stratify the wide range of partial reperfusion that exists between the TIMI 
grades 1 (minimal reperfusion) and 3 (complete reperfusion). The Thrombolysis in 
Myocardial Infarction (TIMI) score (see Table 3) describing distal flow perfusion and 
revascularisation before and following therapy became a standard for reporting cardiac 
reperfusion procedure efficacy (TIMI., 2009). It was applied to intracranial 
thrombolysis, though the TIMI score does not specifically describe both the 
recanalisation effect and the distal perfusion effect simultaneously.  
  
  
Grade 0:  No Perfusion. No anterograde flow beyond the point of occlusion.  
Grade 1:  
Penetration with Minimal Perfusion. The contrast material passes beyond the area of obstruction 
but fails to opacify the entire cerebral bed distal to the obstruction for the duration of the 
angiographic run.  
Grade 2:  
Partial Perfusion. The contrast material passes beyond the obstruction and opacifies the arterial bed 
distal to the obstruction. However, the rate of entry of contrast into the vessel distal to the obstruction 
and/or its rate of clearance from the distal bed are perceptibly slower than its entry into and/or 
clearance from comparable areas not perfused by the previously occluded vessel, e.g., the opposite 
cerebral artery or the arterial bed proximal to the obstruction.  
Grade 2a:  Partial filling with <50% of the entire vascular territory is visualized.  
Grade 2b:  
Partial filling with ≥50% of the entire vascular territory is visualized. If complete filling of all of the 
expected vascular territory is visualised, the filling is slower than normal.  
Grade 3:  
Complete Perfusion. Anterograde flow into the bed distal to the obstruction occurs as promptly as 
into the obstruction and clearance of contrast material from the involved bed is as rapid as from an 
uninvolved other bed of the same vessel or the opposite cerebral artery.  
  
Table 2- Modified Thrombolysis in Cerebral Infarction (TICI) Perfusion  Categories**** Adapted from 
Higashida et al, Stroke2003;34:e109-37  
  
  
    
Table 3 – TIMI Flow Classification*  
 Classification of Blood Flow  
TIMI 0  No Perfusion  
TIMI 1  Penetration without perfusion. Penetration past the initial occlusion, but no distal  branch filling  
TIMI 2  Partial perfusion of the arterywith incomplete or slow distal branch filling  
TIMI 3  Complete perfusion of the artery  
* Adopted from Chesebro et al. Circulation 1987;76:142-154 and Khatri et al, Stroke 
2005;36:2400-2403   
  
  
We will now review the current scoring systems that we have extracted from various 
research papers.  
 
4.13 Collateral scoring systems  
  
4.13.1 Miteff system  
  
Firstly, the Miteff system (Miteff et al., 2009) which is a 3-point score that grades 
middle cerebral artery collateral branches with respect to the Sylvain fissure and which 
can be performed rapidly. The grades assigned are the following: 3 (if the vessels are 
reconstituted distal to the occlusion), 2 (vessels can be seen at the Sylvian fissure), or 
1 (when the contrast opacification is merely seen in the distal superficial branches).   
  
4.13.2 Maas system  
  
Secondly, the Maas system (Mass et al., 2008) which is a 5-point score that compares 
collaterals on the affected hemisphere against those on the unaffected side. It uses the 
Sylvian fissure vessels or leptomeningeal collaterals as internal controls. The score 
ranges from 5 (exuberant), 4 (more than those on the contralateral side), 3 (equal to 
those on the contralateral side), 2 (less than those on the contralateral side), and 1 (no 
vessel opacification).  
  
We have already discussed ASPECTS as a scoring system for ischaemic stroke, but 
collaterals can also be scored using the ASPECTS regions described above. Collaterals 
are scored in regions corresponding to the ASPECTS system. Lenticulostriate arteries 
in the basal ganglia arising from retrograde-filling MCAs distal to an occlusion are 
included in the scoring. The system scores the extent of contrast opacification in 
arteries distal to the occlusion (0, artery not seen; 1, less prominent; 2, equal or more 
prominent compared with a matching region in the opposite hemisphere) in the 6 
ASPECTS cortical regions (M1–6), the caudate, insular ribbon, internal capsule, and 
lentiform nucleus to form a score from 0 to 10.  
  
4.13.3 Tan Score  
  
Finally, we reviewed a paper by Tan (Tan et al., 2009). This novel collateral grading 
system was scored on a scale of 0–3. A score of zero indicated absent collateral supply 
to the occluded MCA territory. A score of 1 indicated collateral supply filling ≤50% 
but >0% of the occluded MCA territory. A score of 2 was given for collateral supply 
filling >50% but <100% of the occluded MCA territory. A score of 3 was given for 
100% collateral supply of the occluded MCA territory. The authors also validated a 
novel clot burden system (CBS), which is a scoring system to define the extent of a 
thrombus found in the proximal anterior circulation by location.  
It is scored on a scale of 0–10. A score of 2 is subtracted if a thrombus is found in each 
of the supraclinoid internal carotid artery (ICA), the proximal half of the MCA trunk, 
and the distal half of the MCA trunk. A score of 1 is subtracted if a thrombus is found 
in the infraclinoid ICA, ACA, and for each affected M2 branch. The thrombus can be 
partially or completely occlusive. A score of 10 is normal, implying clot absence. A 
score of 0 implies complete multisegment vessel occlusion.  
  
4.14 Eloquent Cortex  
  
The eloquent cortex is a name used by neurologists for areas of the cortex that if 
removed will result in loss of sensory processing or linguistic ability and paralysis. 
The most common areas of the eloquent cortex are in the left temporal and frontal 
lobes for speech and language, bilateral occipital lobes for vision, bilateral parietal 
lobes for sensation, and bilateral motor cortex for movement.   
  
Specifically, the localisation of the motor hand area to a hand “knob” area in the 
precentral gyrus was identified by Yousry et al., 1997. However, the mapping of the 
eloquent areas of the brain is a complex procedure due to the large variability of 
functional cortical organisation between individuals (Brett et al., 2002 and Farrell et 
al., 2007). The morphometry of the hand knob is often changed by the infiltration or 
extrusion of the tumours that if located in or near the hand knob can alter results. The 
width, height of hand knob and the distance from tumour to hand knob could serve 
as anatomic biomarkers related to preoperative neurological motor deficits (Jingshan 
et al., 2018), specifically in our case looking at the effects of ischaemia in the area 
post stroke.  
  
The eloquent area itself is shown in the image below (Fig.7). The hand knob area is 




Fig. 7 The eloquent area, represented by the hand knob area (white arrow)- representing motor hand 
function.   
Figure from. “Hand Knob” infarction by Hall J et al., 2008.  
  
 5  Materials and methods  
  
Data was obtained from the SOS Study: A Study of Survival and Outcome After 
Stroke (Clinical Trials Identifier NCT01193569), a study to determine the natural 
history of acute ischaemic stroke from large vessel thromboembolism in the brain. 
The study was a prospective, observational cohort study that enrolled 146 
participants (Study start date: September 2010). The study completion date was 
December, 2016. In the SOS study, patients did not receive endovascular therapy 
due to unavailability of the service and were either not eligible or refractory to lytic 
therapies. All patients had a premorbid mRS of 0. Signed informed consent for this 
study and usage of the data for subsequent studies was available in all cases and 
ethical approval was obtained.   
  
  
Target population   
  
Data for our collaterals evaluation was derived from the SOS study that consisted of a 
stroke cohort who presented within 8 hours from symptom onset with a National 
Institute of Health Stroke Scale (NIHSS) of ≥10 and had evidence of persistent 
occlusion of either the proximal anterior circulation, including the supra-clinoid 
segment of the ICA through the M1 segment of the MCA.   
  
The inclusion and exclusion criteria in the SOS study were as follows:  
  
  
5.1 Inclusion Criteria  
  
• Patients had to be from 18 to 85 years of age  
• Evidence of proximal anterior circulation large vessel occlusion (TIMI 0-1/TICI 
0-1) from CT or MR-Angiography. The target vessel occlusion was allowed to 
include the supra- clinoid segment of the ICA through the M1 segment of the MCA  
• Presented with symptoms consistent with acute ischaemic stroke within 8 hours of 
symptom onset. Patients who presented within 3 hours had to be ineligible or 
refractory to  IV rt-PA therapy  
• At the time of enrolment, the neurological deficit had to result in an NIHSS score 




5.2 Exclusion Criteria  
  
• History of stroke in the past 3 months   
• Pre-existing neurological or psychiatric disease that could confound the study 
results such as a pre-stroke mRS score >1   
• Known severe allergy to contrast media  
• Uncontrolled hypertension (defined as systolic blood pressure >185 mmHg or 
diastolic blood pressure >110 mmHg)   
• CT evidence of the following conditions before enrolment:  
- Significant mass effect with midline shift  
- Evidence of intracranial haemorrhage  
• Treated with endovascular therapy for acute stroke  
• Life expectancy less than 90 days  
  
Patients were unable to receive endovascular therapy at the time, due to an inability to 
provide such service at each centre at the time of trial recruitment.  
  
Additional Inclusion and Exclusion Criteria for purposes of this study   
  
  
The following criteria were added for our collateral evaluation:   
  
Patients needed to present all of the following:   
• Plain, non-contrast enhanced CT at baseline   
• Arterial phase CT-Angiography covering the whole vascular territory •  
 Stroke in the Middle Cerebral Artery (MCA) territory   
• Patients with a transient ischaemic attack (TIA) were not considered.   
  
5.3 Clinical evaluation  
  
Data for neurological and/or function status was available at:  
• Baseline (NIHSS),   
• 24-hours (NIHSS),  
• 7- days (NIHSS) after hospital presentation (or day of discharge from the 
hospital, whichever was earlier).   
Functional outcome as defined by the modified Rankin Scale (mRS) was available 




Datasets from 142 SOS patients were screened for availability of baseline CT and 
source image CT-angiography.  CT-angiographies were evaluated to see if the 
ASPECTS regions were included (high enough coverage) and to make sure the CT-
angiography was of sufficient quality (contrast bolus was timed correctly in the 
arterial and not venous phase). If the bolus was too late and there was no complete 
arterial filling, the data was excluded.  
  
5.4 Image analysis and Training  
  
For our study baseline and follow-up non-contrast CT scans obtained between 24 to 
36 hours after stroke onset were available. In addition, baseline and follow up CT-
Angiography was analysed. The ASPECTS score was assessed on baseline and 
follow-up non-contrast CT scans.  All CT-Angiographies were evaluated according 
to the Tan score.  
  
Image processing  
I extracted the baseline CT and conducted multi-planar reconstructions to straighten 
the anatomy and to show the symmetrical areas as most patients could not be aligned 
symmetrically in the scanner.   
  
Training  
I was trained by my supervisor Professor Grunwald, who has over 25 years of 
experience as a radiologist, on how to interpret CT imaging and how to correlate this 
with ASPECTS and the Tan score. My training lasted three months and I then 
correlated images independently, which were then verified with my supervisor. My 
scoring was consistent with my supervisors’ and I then began to work on our patient 
sample group. Any difficult cases were discussed with my supervisor.  
  
  
Image analysis   
We scored 1040 (20 x 52 patients) ASPECTS areas. I assessed whether and to what 
extent early ischaemic signs were present and the extent according to ASPECTS. 
When available, CT perfusion (multiple time frames) and DSA angiography were 
read.   
  
  
I then evaluated the CT-Angiographic images to confirm the vessel occlusion. Here, 
the CTA source images were evaluated for arterial occlusion and displayed on the 
Aycan console (Aycan, Würzburg, Germany) as MIP (maximum intensity projection) 
reconstructions with 10 mm thickness in the coronary and axial planes. The extent of 
collateralisation in and around the vascular occlusion was mapped and measured by 
the qualitative Tan score. The modified scale of Tan et al. is the simplest system that 
classifies the collaterals as “good” if seen in ≥50% of the MCA territory and “poor” 
when they are seen in <50% of the territory. This system allows a rapid assessment 
and is less prone to differences in opinion.  
  
This score is shown in Table 4 (below)  
  
  
Score description  
0 no collaterals  
1 collateral <50% of the closed area  
2 collaterals >50%, but <100% of the closed area  
3 collaterals 100% of the closed area  
Table 4: Score for the quantification of collaterals in CTA-MIP images in alignment with 





I then scored the 24-hour control CT scans for established ischaemic stroke in all 
1040 regions. (20 regions per patient), looking at the extent of ischaemic damage. I 
then scored the overall TAN score for each case. Finally, I correlated the findings to 







5.5 Statistical analysis  
  
For statistical analysis purposes, SPSS version 15.0 (Statistical Package for the 
Social Sciences) was used. The first step was to test for a normal distribution of the 
data with an exploratory data analysis and the help of the Kolmogorov-Smirnov test 
and Shapiro-Wilk Test under descriptive consideration from frequencies, averages, 
standard deviation as well as the median. All tests were preceded by the formulation 
of a null hypothesis and an alternative hypothesis. For the consideration of normally 
distributed mean values of a random sample, the Student t-test was used. 
Significance levels were presented for both normal and nonnormalised values as 
follows: p>0.05 no significance (ns), p≤0.05 significant (*), p <0.01 very significant 
(**), p < 0.001 highly significant (***).  Without normal distribution the Utest or 





From 146 patients in the SOS dataset 52 were evaluated. Only patients with a complete 
dataset including baseline CT, 24h CT, CT-Angiography and CT-Perfusion were 
included. Patients with posterior circulation stroke were excluded. We also excluded 
patients that had a combination with an ipsilateral anterior cerebral artery stroke and 
patients where source data was not available for the CT-Angiography or initial 
imaging was done using DYNA-CT (A CT-scan acquired on the catheter lab 
angiography table) or baseline or FU imaging was done using MRI.  
  
  
6.1 Baseline Patient Characteristics  
  
All 52 patients (26 males and 26 females) had a morphologically proven ischaemic 
territorial infarction that did not necessarily include the cortex in the cerebral artery 
area and involvement of the motor system.  
The mean age of the patients at the time of the index stroke was 76± 6 years. The 
most common cerebrovascular risk factor was arterial hypertension (present in 5% of 
patients), followed by hyperlipidaemia (present in 4% of patients), nicotine abuse 
(present in 3% of patients) and diabetes mellitus (present in 2% of patients).   
  
• 92.3% (48/52) of the patients were right-handed, 5.8% (3/52) left-handed and 
1.9% (1/52) ambidextrous.   
  
• 54% (28/52) of patients suffered a stroke on the right side of the brain and 
46% (24/52) suffered a stroke on the left side of the brain (Fig.8).    
  
• 40.4% (21/52) of stroke lesions were reported within the dominant 
hemisphere of the patient, whereas 59.6% (31/52) of ischaemic changes 
appeared in the non-dominant hemisphere.  
  
• 100% (28/28) of stroke lesions on the right side occurred in the non-dominant 
hemisphere. 87.5% (21/24) of stroke lesions on the left side occurred in 
dominant hemisphere and 12.5% (3/24) within non-dominant hemisphere.  
 
Fig.8 Pie-chart illustrating the % of patients suffering a right/left sided stroke  
  
6.2 Baseline Imaging Results  
  
Collaterals   
  
Collaterals were scored according to the Tan Score. The distribution was as 
follows:  
  
TAN score (See Table 5 and Fig. 9 below)  
• TAN score = 0 in 8 %  
• TAN score = 1 in 27 %  
• TAN score = 2 in 44 %  




TAN_Score (NIHSS Correlation)    
  Number   
 
Percentage (%)   
 0   4    7.69 
 1   14    26.92 
 2   23    44.23 
 3   11    21.15 
 Missing   0    0 
  
Table 5: Distribution of Tan scores.  
  
  
Right sided stroke 
54 % 
Left sided stroke 
46 % 
% of patients with R/L sided stroke 
Right sided stroke 
Left sided stroke 
  
  
Fig. 9 Pie Chart of individual TAN Scores represented in a pie-chart in percentage. TAN score of 0: no 
collateral, TAN score of 3: full collaterals.  
  
  
None of the images had evidence of ICH at baseline.   
  
mRS score was recorded at 90 days as a marker of patient 
outcome. The distribution of the scores from 0-6 were as follows  
• 0- 0%  
• 1-  1.2%  
• 2-  5.1%  
• 3-  15.4%  
• 4-  37.6%  
• 5-  15.4%  
• 6-  25.3%  
  
ASPECTS regions were affected as follows (See Fig.10 below):  
• M1 48%  
• M2 76%   
• M3 50%  
• M4 35%  
• M5 67%  
• M6 39%  
  
  




67.5% of patients had a drop in ASPECT’s score from baseline to 24hrs, with an 
average decrease of two points.  
  
  
6.3 Statistical Results 
  
  
1)  Correlation between TAN score (collaterals) and outcome (mRS; NIHSS) 
An increasing TAN score appears to be associated with a lower mRS score 
(p=0.048; 95% CI) meaning that patients with better collaterals had a better 
outcome (Table 6 below).   
This however did not reach significance on the NIHSS score.   
  
Table 6  
Region  NIHSS coefficient  NIHSS p-value  mRS coefficient  mRS p-value  










 FU_ASPECTS (Tan)   
  Number    Percentage (%)    Cumulative percentage (%)   
 0  6  11.53   11.53 
 1  6  11.53   23.07 
 2  4  7.69   30.76 
 3  10  19.23   50.00 
 4  7  13.46   63.46 
 5  6  11.53   75.00 
 6  3  5.76   80.76 
 7  2  3.84   84.61 
 8  4  7.69   92.30 
 9  1  1.92   94.23 
 10  1  1.92   96.15 
 Braki  2  3.84   100.00 
  
Table 7: There was a positive correlation between the Tan score and the ASPECTS 
score (p=0.049; p<0.05).   
  
3.) correlation between individual ASPECTS areas and functional outcome (mRS; 
NIHSS)  
  
We used linear regression models for NIHSS, and ordinal logistic regressions for 
mRS. In both cases a coefficient equal to zero implies no effect of damage in the 
region, greater than zero implies an increase in NIHSS or mRS score, and less than 
zero implies a reduction in score.  
Table 8 (below) shows that M2 and M4 are associated with an increase in NIHSS. M2 
and M5 are associated with an increase in mRS.  
  
Region  NIHSS coefficient  NIHSS p-value  mRS coefficient  mRS p-value  
M1  2.91 (-1.81, 7.62)  0.220  1.10 (-0.01, 2.21)  0.051  
M2  6.01 (0.71, 11.30)  0.027  1.50 (0.24, 2.75)  0.019  
M3  2.81 (-1.91, 7.52)  0.236  0.46 (-0.59, 1.52)  0.390  
M4  6.50 (1.74, 11.25)  0.009  0.94 (-0.18, 2.06)  0.100  
M5  2.64 (-2.38, 7.66)  0.294  1.35 (0.19, 2.51)  0.023  
M6  3.88 (-0.91, 8.66)  0.109  1.16 (0.026, 3.15)  0.045  
Table 8:  M2 and M4 are associated with an increase in NIHSS. M2 and M5 are associated with an  
increase in mRS.  
  
  
4.) Does a higher ASPECTS score (more affected areas) correlate with a better 
functional outcome? (lower mRS and lower NIHSS)   
   
Here a coefficient less than zero implies that an increase in ASPECTS score (less 
damage) implies a reduction in NIHSS and mRS scores.  
  
Both outcomes are significant (Table 9).  
  
This is also illustrated by Fig. 11 and Fig.12 (below) respectively.  
 
 Region  NIHSS coefficient  NIHSS p-value  mRS coefficient  mRS p-value  
 ASPECTS score  -0.99 (-1.92, -0.05)  0.039  -0.32 (-0.52, -0.12)  0.002  
 
Table 9: an increase in ASPECTS score (less damage) implies a reduction in NIHSS and mRS 














Fig. 12 Graph showing mean mRS at 90 days against ASPECTS score, again the statistical analysis revealed a 




5.) Does having a stroke in the dominant side predict a lower mRS or NIHSS?  
  
If the coefficient is greater than zero, having the dominant side affected implies an 
increase in NIHSS or mRS scores. There appeared to be no effect.  
Region  NIHSS coefficient  NIHSS p-value  mRS coefficient  mRS p-value  
Dominant side?  2.91 (-1.78, 7.60)  0.218  0.25 (-0.76, 1.25)  0.630  
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7 Discussion  
  
A lot has happened in the acute treatment of ischaemic stroke. In the past, only 
intravenous lysis therapy was available, which had to be applied within three hours 
after exclusion of bleeding by CT or MRI. Today different rules apply.  Not only has 
the timeframe of thrombolysis been extended to 4.5 hours (Hacke et al., 2008) but 
mechanical thrombectomy has expanded the treatment spectrum in ischaemic stroke 
(Smith et al., 2008). In early 2015, five independent randomised trials were published: 
ESCAPE (Goyal et al., 2015) EXTENDIA (Campbell et al., 2015), MR CLEAN 
(Berkhemer et al., 2015), REVASCAT (Jovin et al., 2015) and SWIFT-PRIME (Saver 
et al., 2005). These studies demonstrated the real superiority of endovascular stroke 
treatment. Interventional techniques are now available in all major stroke centres but 
questions now revolve around patient selection, whether to transport a stroke patient 
to a specialist thrombectomy centre and which patients may benefit beyond the 6-hour 
window from recanalisation, whether by intravenous lysis or by endovascular 
intervention.  
  
Studies such as the one by Nogueira et al. (2018) (DAWN) and Albers et al. (2018) 
(DEFUSE-3) have begun to shift the paradigm away from the traditional time 
windows for interventional endovascular therapy.  The DAWN Study (Nogueira et 
al.,2018) triaged patients with wake-up and late presenting strokes for 
neurointervention with the Trevo device according to DWI or CTP Assessment. The 
trial showed that the time window for endovascular treatment may be extended to 24 
hours after the patient was last known to be well if patients are carefully selected on 
the basis of a disproportionately severe clinical deficit in comparison with the size of 
the stroke on imaging. In the DAWN study, infarct volume was seen as a predictor 
of outcome (smaller infarct volume patient’s being chosen for the study).  
  
The Endovascular Therapy Following Imaging Evaluation for Ischemic Stroke 
(DEFUSE 3) trial (Albers et al., 2018) showed that patients with anterior circulation 
stroke and remaining, intact ischemic brain tissue who received thrombectomy 6-16 
hours after last known well, had better functional outcomes than patients treated with 
standard medical therapy. Patients needed to have an initial infarct size of less than 
70 ml and a ratio of the volume of ischaemic tissue on perfusion imaging to infarct 
volume of 1.8 or more.    
  
  
Patient selection in these studies was crucial as patients were chosen based on their 
infarct volume, identified by perfusion scanning or DWI-MRI.   
  
My study adds a different but critical angle to the literature, to what is already known 
and has ramifications for patient selection suitable for stroke therapies.  
  
The patient group in my study had suffered a stroke with persistent large vessel 
occlusion but, importantly, they were not recanalised. In fact, occlusion of the vessel 
was confirmed 2-4 days post event. Thus, clinical results will not be confounded by 
early reperfusion caused by reopening of the vessel.  My study results have shown that 
those patients with poor collaterals will have less salvageable brain tissue and hence 
poorer outcomes. Our results also suggest that those with good collaterals may 
potentially have areas of the brain which remain salvageable, whether that be 
temporary or permanent and it is in this cohort of patient’s where treatment could still 
be beneficial, regardless of a time-window. This also has implications for secondary 
referrals to thrombectomy capable centres.  I will now go on to explain these results 
in more detail.  
   
In our study we evaluated a unique group of patients that presented with persistent 
large vessel occlusion. My results showed an increasing TAN score appears to be 
associated with a lower mRS score (p=0.048; 95% CI). There was a positive 
correlation between the ASPECTS score and the Tan score (p=0.049; p<0.05). The 
M2 and M4 regions were associated with an increase in NIHSS (p= 0.027; 0.009); the 
M2 and M5 regions were associated with an increase in mRS (p= 0.019; 0.023). An 
increase in ASPECTS score (less damage) implied a reduction in the NIHSS and mRS 
score (better outcome).  
  
We found a positive correlation between the ASPECTS score and the Tan score. This 
is in accordance with studies on patients with recanalisation therapies (Bang et al., 
2011).  A low ASPECTS score was positively correlated with the Tan score (0.049, 
p<0.005).   
  
Collaterals have already been reported to affect the rate of infarct growth, perfusion 
providing indirect information about this downstream collateral supply to the 
ischaemic tissue. Vagal et al. investigated associations between computed tomography 
angiography (CTA) of collaterals and parameters of perfusion in the IMS III trial. The 
authors showed an association between the status of collaterals in the CTA and the 
CTP parameters as part of a randomised study design. The limitations of their study 
lie in the post-hoc analysis, along with a small sample size. In addition, the IMS III 
study was a multicentre study with significant heterogeneity in the technique of CTA 
and varying recanalisation rates.   
  
In our study we concentrated only on patients with persistent LVO. All patients had 
repeat CTA to demonstrate persistent occlusion, having the advantage that changes in 
NIHSS cannot be attributed to vessel recanalisation but instead to the extent of 
collateral supply and eloquent area. The extent of this collateral supply is shown in the 
analysis of 3,681 patients with carotid stenosis treated since 1995 at the Western 
University in Ontario (Executive Committee for the Asymptomatic Carotid 
Atherosclerosis Study, 1995 and Johnson et al., 1995). In 316 patients, the carotid 
artery was already occluded when the patients presented in the clinic. Of those patients, 
only one (0.6%) had a stroke previously. Three more patients (0.9 %) suffered a stroke 
during follow up. The analysis showed that neither the extent of the stenosis nor any 
occlusion of the other carotid type made the stroke predictable.   
  
The selection of patients for thrombolytic therapy is conventionally based on a strict 
time windows (4.5 hours for intravenous thrombolysis, and 6-8 hours for mechanical 
thrombectomy) as well as the extent of infarction in the initial CT imaging. ASPECTS 
scores of 5 or 6 and above have been applied in previous thrombectomy studies. 
However, these criteria are insufficient to predict the individual outcome of a patient. 
It is all about balancing the benefit of reperfusion versus the risk of haemorrhage.   
  
An individual selection based on individual physiological criteria (Jovin et al., 2002) 
would be a better example e.g. the neurological outcome after stroke depends, among 
others, on the residual blood flow during vascular occlusion (Muir et al., 2006).  This 
can be determined by means of the perfusion CT parameters (Schaefer et al., 2007).  
A cerebral blood volume (CBV) below 2 ml / 100 g of brain tissue in CT perfusion is 
considered to be already infarcted with a statistical probability of 93% (Wintermark et 
al., 2006). Lansberg et al. published the CRISP study (CT Perfusion to Predict 
Response to Recanalisation in Ischaemic Stroke Project), which addressed prediction 
of CT perfusion in terms of outcome. The aim of the study was to find out if patients 
with infarct core mismatch in CT perfusion benefitted from thrombectomy as 
compared to patients without mismatch in CT perfusion. They found that patients with 
a mismatch in CT perfusion had a 6.6-fold higher chance of a good outcome after 
mechanical thrombectomy. A good outcome was rated as a reduction of the NIHSS by 
at least 8 points or as a NIHSS ≤ 1 point 30 days after intervention (Lansberg et al., 
2017). However, the study cannot be compared directly with ours, as our patients were 
not recanalised. There are currently various semi quantitative (visual penumbra 
estimation, ASPECTS evaluation studies (Aviv et al., 2008 and Lee et al., 2008) and 
quantitative evaluation algorithms (Klotz et al., 1999).  
  
Occlusion localisation could be considered as another important parameter for 
deciding on thrombectomy. However, there are currently no studies in which 
thrombectomy was performed in a highly selected patient population (occlusions of 
the major cerebral arteries) based on collateral status. Outcome after thrombectomy 
depends, among other things, on the residual blood flow maintained by the collateral 
system. These are inter- individually very diverse and differently developed (Fisher et 
al., 2006). Despite the great potential for characterising the collaterals by means of 
invasive methods such as digital subtraction angiography or noninvasive methods such 
as CT or MR- angiography or even transcranial Doppler sonography, until recently, 
no great importance was attributed to this methodology. Thus, so far, collaterals play 
no established role in acute stroke imaging.  As early as 2004, Schramm et al. showed 
that the extent of collaterals in CT angiography is a surrogate parameter for residual 
blood flow. Later, Christoforidis et al. were able to demonstrate the connection 
between collateral systems and clinical outcome or bleeding events in two studies. 
Finally, Tan et al. demonstrated that CTA-MIP reconstruction is better at assessing 
collateral circuits than CTA source images. Furthermore, his working group developed 
a semi quantitative score based on the visual assessment of the extent of collaterals in 
the ischaemic stream area. In a heterogeneous patient population, they were able to 
show in a retrospective analysis that this score correlated with the final infarct volume 
with a good scorer agreement (Tan et al., 2007).  
  
Modern imaging techniques including the collateral status could help physicians find 
their way to the best therapy. However, there is still a lack of data. The role of 
collaterals and their consequences for stroke care and especially patient selection are 
still under discussion. Some academics see collateral blood flow as an indicator of a 
better therapeutic outcome, as the damage caused by arterial occlusion is partially 
offset by these alternative routes of delivery. Collateral recruitment depends on a range 
of collateral features including the size of the vessel, the direction of flow, the patency 
of the pathways and the speed of filling (Liebeskind et al., 2003; Malhotra & 
Liebeskind et al., 2020). The lack of collateral circulation, on the other hand, was 
shown to be a risk factor for secondary haemorrhage and space-occupying infarcts.  
Whether the existence of good collaterals will guide decisions about treatment options 
is still a topic of discussion, as is the most appropriate modality for assessing the 
collateral status.  In addition to collateralisation, there are a few other parameters that 
could help gauge the sense or nonsense of recanalisation.  An approach is to use not 
only standard perfusion measurements in assessing ischaemic damage, but also more 
complex parameters such as cerebral blood volume (CBV), or the mean transit time of 
the blood (MTT). Recently it was shown that perfusion could be used to reliably 
identify brain areas with the help of CT perfusion imaging, which would still benefit 
from thrombectomy up to 12 hours (Wannamaker et al., 2018). In doing so, CBV 
perfusion of a brain area affected by the stroke was correlated to the MTT. If the MTT 
area was significantly larger than the CBV disturbed area, it was assumed that the 
socalled penumbra tissue could still be saved by recanalisation.  
  
We found that ASPECTS on follow up correlated with the improvement of the NIHSS 
between admission and discharge, i.e. the short-term outcome. This is consistent with 
previously published studies (Aviv et al., 2007 and Popiela et al., 2008). Perfusion CT 
in acute stroke: prediction of vessel recanalisation and clinical outcome in intravenous 
thrombolytic therapy (Kloska et al., 2007), in which ASPECTS-CBV was identified 
as the best predictor of outcome in patients treated with or without thrombolysis. 
However, these studies invariably used the mRS after three months to identify the 
outcome.  
  
A high initial NIHSS has been described as a predictor of a worse outcome (Wechsler 
et al, 2003).  Interestingly, in the present study there was no correlation between initial 
NIHSS and outcome which seems to contradict the widely accepted finding that 
patients with high NIHSS are generally poor outcome candidates after thrombolysis 
(Gasparotti et al., 2007). However, contrary to other studies, none of our patients had 
a recanalisation of the vessel and the initial NIHSS was already high with minimal 
inclusion criteria of NIHSS.   
  
Handedness: An explanation for the negative predictive value of previous studies 
could be related to the assignment of brain areas to functions. In the primary areas of 
the cerebral cortex with sensorimotor function, the assignment of anatomy to function 
is very reliable and varies little between individuals. However, this applies to a limited 
extent only to secondary areas of the cerebral cortex such as the language. The 
language areas vary in individual humans not only with respect to the speech-dominant 
hemisphere, but also anatomically within certain limits, so that the exact anatomical 
assignment on an individual basis is limited. Thus, it may be that in some patients a 
speech disorder was present, which was already in an infarcted area, which we had 
mistakenly not assigned to the language function. Also, we did not pay attention to the 
handedness of the patients, so that we could not draw any indirect conclusions about 
the language dominant hemisphere. In the case of stroke in the right hemisphere, 
problems with orientation, attention, and creativity, among others, may occur; 
however, this is not reflected in our conventional functional tests (mRS and NIHSS). 
If the left hemisphere is damaged, the language is often disturbed which strongly 
reflects in both scores.  
  
We conclude that strokes affect the patients left hemispheres more often (Hedna et al., 
2013) but left sided strokes are not more severe, yet are causing more deficits in 
conventional outcome tests. The speech region is in right-handed patients on the left 
side of the brain (and in a percentage of left-handers). If loss of the language or loss 
of the ability to speak and count occurs, the deficit will be dramatic. In addition, in left 
sided infarction, the right hand is affected, which is also a serious drawback for those 
who are right-handed. Although patients with a left sided infarct had a better outcome 
on their NIHSS, it is wrong to believe that right sided infarcts are harmless. They also 
lead to hemiplegia with orientation disorders and visual field defects. The patient often 
does not notice partial visual field defects which can lead to tragic accidents when in 
traffic. Neglect of the paralysed body side and attention deficits are other stroke 
symptoms in the right hemisphere. It has also been reported that patients with right 
sided strokes are more prone to depression (MacHale et al., 1998).  Deficits of the left 
side, such as the speech disorders, are more obvious, whilst right hemispheric stroke 
symptoms can sometimes go unnoticed.  
  
Our results showed that M2 and M4 areas were associated with an increase in NIHSS 
(p= 0.027; 0.009) meaning more disability and M2 and M5 areas were associated with 
an increase in mRS (p= 0.019; 0.023) and greater morbidity. These areas in the brain 
do not have one specific function but have a complex overlay of roles, which are still 
to be fully elucidated. What we can say from our results is patients with good 
collaterals in the M2 and M4 region, where no stroke developed, were more likely to 
have a lower NIHSS score.   
  
But what of those patients who present outside of the time window. One in five strokes 
are classified occur during sleep (wake-up stroke). People with wake-up stroke have 
traditionally been considered ineligible for recanalisation therapies because the time 
of stroke onset is unknown. The DAWN and DEFUSE-3 trials have shown the efficacy 
of thrombectomy in selected patients with occlusion of proximal vessels in the anterior 
circulation up to 24 h after suspected onset of symptoms. A recent Cochrane review 
(Roaldsen et al., 2018) has also shown there is insufficient evidence from randomised 
controlled trials for recommendations concerning recanalisation therapies for wake-up 
stroke. Our study has shown that patients who present outside the time window for 
traditional recanalisation therapies may potentially have salvageable brain tissue 
depending on their collateral status. Whether or not these patients would benefit from 
systemic recanalisation therapies or endovascular therapies is yet to be determined, 
but the importance of collaterals cannot be forgotten and may offer a lifeline for a 
specific subsection of patients.  
  
How do our results compare with what is already known?  
  
The majority of research on collaterals has focused on stroke patients receiving 
intravenous thrombolysis within 4.5 hours from last known well or undergoing ET 
within 6 hours from last known well. The effect of leptomeningeal collaterals for 
acute ischaemic stroke patients with large vessel occlusion in the late window (>6 
hours from last known normal) remains unknown. Areas of the brain that typically 
lack or have poor leptomeningeal collateral support, such as the basal ganglia, are 
likely to be infarcted more rapidly in proximal ICA/MCA occlusions (Shapiro et al., 
2020).  
  
DEFUSE 3 provided evidence that ischaemic stroke patients with occlusion of the 
cervical or intracranial internal carotid artery or the proximal middle cerebral artery 
and salvageable brain tissue on perfusion imaging, benefit from ET as opposed to 
medical therapy alone, 6 to 16 hours after last known well (Albers et al., 2018). 
Although multiphase CTA has been shown to very accurately measure collateral 
status (Menon et al., 2015) the DEFUSE 3 cohort had a single phase CTA, which has 
also been validated as a reliable modality for collateral measurement and is widely 
used clinically.  Some studies have demonstrated that good collateral status is 
associated with reduced ischaemic core growth (de Havenon et al. 2019). De 
Havenon et al., 2019 looked to determine if collateral status on baseline CT 
angiography (CTA) impacted neurologic outcome, ischaemic core growth and 
moderated the effect of endovascular thrombectomy (ET) in the late window. They 
found that good collaterals were associated with significantly smaller ischaemic core 
volume and less ischaemic core growth, a reliable biomarker of neurologic outcome. 
They did not however find that good collaterals affected neurological outcomes. 
There could be several explanations for this, firstly the collateral circulation 
ultimately fails in the majority of stroke patients with large vessel occlusion who are 
not recanalised (Lansberg et al., 2001). The ischaemic core of the DEFUSE 3 
patients with good collaterals, particularly those who were not recanalised, may have 
continued to grow after the 24-hour follow-up imaging and ultimately be comparable 
to patients with poor collaterals. Limitations of their study included selection bias 
(CTA as baseline imaging only),  
  
Further assessment of collaterals in our cohort and others’ at various intervals (up to 
five days) after acute stroke insult may help to answer these questions such as also 
provide valuable information on collateral evolution over time. As previously 
discussed, this is dependent on dynamic factors, such as intravascular volume, 
adrenergic tone, blood pressure, brain oedema, temperature and medications being 
administered (Rocha et al., 2017).  
  
Without a better understanding of collateral evolution, we will not fully appreciate 
their effect on neurologic outcome or comprehend how to therapeutically modify 
that effect. There is also a lack of consensus on the optimal collateral grading system 
based on non-invasive imaging modalities in acute ischaemic stroke (Ravindran et 
al., 2020)  
  
Crucially, our study results show that those patients with good collaterals potentially 
have brain tissue which is still salvageable - and the selection of these patients for 
transfer to a tertiary centre, for endovascular treatments, is key. We speculate that, in 
the future, stroke physicians will treat patients not just on infarct volumes (as in the 
DAWN study), but will also include the collateral status.  Collaterals also have an 
important role to play in the survival and sustenance of hypoperfused tissue following 
an acute ischaemic stroke, especially in assisting patient selection for endovascular 
therapy, in an extended time window and identifying those who are more likely to 
benefit, so that the benefits of acute neurointervention are compounded and therefore 
translated into a significant favourable clinical advantage (Amaro et al., 2019; Beretta 
et al., 2017; Nishijima et al., 2015).  
  
The first attempts have already been made.  Artificial Intelligence companies such as 
Brainomix Inc. (Brainomix Inc. Oxford, UK) have added assessment and scoring of 
collaterals to their e-stroke portfolio. Their software now automatically calculates 
infarct volume by recognising subtle differences in brain densities, identifies occluded 
vessels and analyses the collateral status.  The game changer in our study is that it 
negates the need for CT-perfusion scans, which add to the complexity of stroke 
imaging. This saves time and also protects the patient from additional radiation and 
contrast agent. Also, perfusion imaging and interpretation is currently only available 
in a few selected centres in the UK whereas CTA, which is required to identify large 
vessel occlusion strokes, is available in most centres in the United Kingdom. 
Assessment of collateral status would remove the need for any additional imaging 
(except baseline CT) and could help decide which patients are suitable candidates for 
transfer to tertiary stroke centres for intervention. For patients with poor collaterals 
that cannot be recanalised in time, we would expect the areas affected to develop 
ischaemic tissue early. This has immediate effect on the clinical management as 
patients with poor collatereals will develop malignant brain swelling early. They thus 
require diligent, clinical monitoring with  decompressive surgery being 
discussed/planned at an early stage, where as those with good collaterals are likely to 
have more reserve and will potentially develop a smaller infarct with more brain tissue 




A limitation of our study was the small sample size, and this was predominantly down 
to patient’s not matching our inclusion criteria, alongside missing source image data-
sets. Our data only evaluated anterior circulation strokes and a complete dataset was 
required to assess late opening of the vessel and infarct volume at 24 hours.   
  
Another limitation is that the thrombus length was not evaluated. Riedel et al. 
postulated that very long thrombi are more difficult to resolve with intravenous lysis 
than short thrombi and this may play a role in recanalisation. However, we could show 
that none of our patients recanalized, thus diminishing this confounder.   
  
Neurological outcome is also dependent on the side and localisation of the occlusion. 
Although we differentiated between dominant and non-dominant hemisphere in our 
analysis we did not differentiate between different eloquent areas which, except for 
the hand knob, would have required additional functional imaging.  
  
Although our patients had confirmed large vessel occlusions at days 2-4 post 
admission, we cannot be sure that the vessel did not spontaneously recanalise at a later 
date. However, we would expect most ischemic damage to have developed by this 
time. Unfortunately, funding did not permit an in-person assessment (NIHSS) at 90 
days and only the mRS was collected (via telephone interview), thereby limiting a 
more detailed analysis of specific neurological function. However, mRS is considered 
a universal outcome measure in the majority of stroke studies.   
  
  
Advantages:   
Our study is the first study evaluating the role of collaterals in patients with persistent 
MVO and opens a paradigm for those who are not amenable to thrombolysis or 
endovascular treatment yet may have a good outcome.  
A particular strength of our study is that we also evaluated the dominant hemisphere 
in patients which is commonly ignored and is known to have a huge impact on outcome. 
One advantage of our study was that in most cases collaterals could be visualised by 
CT angiography as well as by MRI.  Furthermore, patients with different occlusion 
sites were included in our study. Patients in the PROACT study (ClinicalTrials.gov 
Identifier: NCT03767595) showed only M1 or M2 occlusions. Arnold et al. treated 
both proximal M1 and M2 segments and distal occlusions (M3 and M4 segments) of 
the middle cerebral artery.  
None of the previous studies have evaluated eloquent regions such 
as the   Central Region Hemiparesis for hemi-hyperaesthesia.  
 Internal capsule for hemi-hyperaesthesia + hemiparesis  
 Parieto-occipital region for hemianopia  
 Frontal region for Broca aphasia   













8 Conclusion  
  
Pathophysiologic measures of existing collaterals can characterise brain reserve prior 
to endovascular thrombectomy and will likely facilitate patient selection for this 
promising but expensive treatment, which is currently subject to arbitrary time 
parameters that derive from population studies, before modern imaging techniques 
were available. Overall, my results revealed that collateral formation has a significant 
impact on patient outcome with statistically significant results in the M4, M5 and M6 
areas, especially in the eloquent cortex affecting motor hand movement. My results 
add weight by moving away from rigid time windows for potential stroke treatments. 
The assessment of patients from initial imaging and collateral formation will only help 
to serve this important lifesaving treatment and adds another tool to a stroke 
physician’s arsenal. We hope that in the future patients will be treated according to 
their own clinical merit. The importance of mechanical thrombectomy and access to 
interventional clinicians will be key in treating these patients.  This is only the start of 
what is the first study to evaluate the role of collaterals in persistent large vessel 
occlusion and their impact on outcome.  
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10 Abbreviations:   
  
A: Artery  
ACA: Anterior cerebral artery  
ICA:  Internal Carotid Artery   
MCA:  Middle Cerebral artery  
ASPECTS: Alberta Stroke Program Early CT Score  
C: contrast  
CBF: Cerebral Blood Flow  
CBV: Cerebral Blood Volume  
CCT: cranial computed tomography  
CRISP: CT Perfusion to Predict Response to Recanalization in Ischemic Stroke  
CT: Computed Tomography   
CTA: Computed Tomography Angiography  
CW: Circle of Willis  
DAWN study: DWI or CTP Assessment with Clinical Mismatch in the Triage of  
Wake Up and Late Presenting Strokes   
DSA: Digital subtraction angiography  
DWI: Diffusion Weighted Imaging  
EPITHET: Echoplanar Imaging Thrombolytic Evaluation Trial  
ESCAPE: Endovascular treatment for small core and anterior circulation proximal occlusion with 
emphasis on minimizing CT to recanalization times  
EXTEND-IA: Extending the time for thrombolysis in emergency neurological deficits with intra-
arterial therapy   
FDA: Food and Drug Administration  
FLAIR Fluid Attenuated Inversion Recovery   
MRA: Magnetic resonance angiography  
MR Clean Multi-centre randomised clinical trial of endovascular treatment for acute ischemic 
stroke in the Netherlands.  
mRS: Modified Rankin 
Score MRI: Magnetic 
resonance imaging MTT: 
Mean Transit Time:  
NIHSS National Institute of Health Stroke 
Scale rt-PA: reverse- Tissue plasminogen 
activator  
SWIFT-PRIME: Solitaire With the Intention for Thrombectomy as Primary Endovascular 
Treatment for Acute Ischemic Stroke  
TICI: thrombolysis in cerebral infarction  
TIMI: Thrombolysis in myocardial infarction 
